Abstract
PURPOSE: An autoantibody test (AABT) has been recently developed as an aid to early detection of lung cancer in high-risk patients. While less sensitive than computed tomography (CT), it can detect smaller, less advanced cancers and has greater specificity than CT. The cost-effectiveness of screening for lung cancer using AABT is unknown.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
